Renal Therapeutic Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Renal Therapeutic Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Chronic kidney disease (CKD) is a slow and progressive loss of kidney function over several years. Eventually, a person may develop kidney failure.
This report aims to provide a comprehensive presentation of the global market for Renal Therapeutic study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Renal Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Renal Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Angiotensin-II Receptor Blockers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Renal Therapeutic include Merck & Co., Inc., Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Vifor Pharma Inc., Johnson & Johnson Services, Inc., Amgen Inc., Bayer AG and AstraZeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Renal Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Renal Therapeutic Market, by Drug Type, 2017-2022, 2023-2028 ($ millions)
Global Renal Therapeutic Market Segment Percentages, by Drug Type, 2021 (%)
Angiotensin-II Receptor Blockers
ACE Inhibitors
Calcium Channel Blockers
Beta-blockers
Others
Global Renal Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Renal Therapeutic Market Segment Percentages, by Application, 2021 (%)
Chronic Kidney Disease
Diabetes
Kidney Stone Disease
Renal Failure
Others
Global Renal Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Renal Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Renal Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc.
Vifor Pharma Inc.
Johnson & Johnson Services, Inc.
Amgen Inc.
Bayer AG
AstraZeneca
Vifor Pharma Group
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Renal Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Drug Type
1.2.2 Market by Application
1.3 Global Renal Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Renal Therapeutic Overall Market Size
2.1 Global Renal Therapeutic Market Size: 2021 VS 2028
2.2 Global Renal Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Renal Therapeutic Players in Global Market
3.2 Top Global Renal Therapeutic Companies Ranked by Revenue
3.3 Global Renal Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Renal Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Renal Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Renal Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Renal Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Drug Type - Global Renal Therapeutic Market Size Markets, 2021 & 2028
4.1.2 Angiotensin-II Receptor Blockers
4.1.3 ACE Inhibitors
4.1.4 Calcium Channel Blockers
4.1.5 Beta-blockers
4.1.6 Others
4.2 By Drug Type - Global Renal Therapeutic Revenue & Forecasts
4.2.1 By Drug Type - Global Renal Therapeutic Revenue, 2017-2022
4.2.2 By Drug Type - Global Renal Therapeutic Revenue, 2023-2028
4.2.3 By Drug Type - Global Renal Therapeutic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Renal Therapeutic Market Size, 2021 & 2028
5.1.2 Chronic Kidney Disease
5.1.3 Diabetes
5.1.4 Kidney Stone Disease
5.1.5 Renal Failure
5.1.6 Others
5.2 By Application - Global Renal Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Renal Therapeutic Revenue, 2017-2022
5.2.2 By Application - Global Renal Therapeutic Revenue, 2023-2028
5.2.3 By Application - Global Renal Therapeutic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Renal Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Renal Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Renal Therapeutic Revenue, 2017-2022
6.2.2 By Region - Global Renal Therapeutic Revenue, 2023-2028
6.2.3 By Region - Global Renal Therapeutic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Renal Therapeutic Revenue, 2017-2028
6.3.2 US Renal Therapeutic Market Size, 2017-2028
6.3.3 Canada Renal Therapeutic Market Size, 2017-2028
6.3.4 Mexico Renal Therapeutic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Renal Therapeutic Revenue, 2017-2028
6.4.2 Germany Renal Therapeutic Market Size, 2017-2028
6.4.3 France Renal Therapeutic Market Size, 2017-2028
6.4.4 U.K. Renal Therapeutic Market Size, 2017-2028
6.4.5 Italy Renal Therapeutic Market Size, 2017-2028
6.4.6 Russia Renal Therapeutic Market Size, 2017-2028
6.4.7 Nordic Countries Renal Therapeutic Market Size, 2017-2028
6.4.8 Benelux Renal Therapeutic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Renal Therapeutic Revenue, 2017-2028
6.5.2 China Renal Therapeutic Market Size, 2017-2028
6.5.3 Japan Renal Therapeutic Market Size, 2017-2028
6.5.4 South Korea Renal Therapeutic Market Size, 2017-2028
6.5.5 Southeast Asia Renal Therapeutic Market Size, 2017-2028
6.5.6 India Renal Therapeutic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Renal Therapeutic Revenue, 2017-2028
6.6.2 Brazil Renal Therapeutic Market Size, 2017-2028
6.6.3 Argentina Renal Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Renal Therapeutic Revenue, 2017-2028
6.7.2 Turkey Renal Therapeutic Market Size, 2017-2028
6.7.3 Israel Renal Therapeutic Market Size, 2017-2028
6.7.4 Saudi Arabia Renal Therapeutic Market Size, 2017-2028
6.7.5 UAE Renal Therapeutic Market Size, 2017-2028
7 Players Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporate Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Renal Therapeutic Major Product Offerings
7.1.4 Merck & Co., Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
7.1.5 Merck & Co., Inc. Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Renal Therapeutic Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Renal Therapeutic Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Renal Therapeutic Major Product Offerings
7.3.4 Novartis AG Renal Therapeutic Revenue in Global Market (2017-2022)
7.3.5 Novartis AG Key News
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Corporate Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Renal Therapeutic Major Product Offerings
7.4.4 Pfizer Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
7.4.5 Pfizer Inc. Key News
7.5 Vifor Pharma Inc.
7.5.1 Vifor Pharma Inc. Corporate Summary
7.5.2 Vifor Pharma Inc. Business Overview
7.5.3 Vifor Pharma Inc. Renal Therapeutic Major Product Offerings
7.5.4 Vifor Pharma Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
7.5.5 Vifor Pharma Inc. Key News
7.6 Johnson & Johnson Services, Inc.
7.6.1 Johnson & Johnson Services, Inc. Corporate Summary
7.6.2 Johnson & Johnson Services, Inc. Business Overview
7.6.3 Johnson & Johnson Services, Inc. Renal Therapeutic Major Product Offerings
7.6.4 Johnson & Johnson Services, Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Services, Inc. Key News
7.7 Amgen Inc.
7.7.1 Amgen Inc. Corporate Summary
7.7.2 Amgen Inc. Business Overview
7.7.3 Amgen Inc. Renal Therapeutic Major Product Offerings
7.7.4 Amgen Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
7.7.5 Amgen Inc. Key News
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Renal Therapeutic Major Product Offerings
7.8.4 Bayer AG Renal Therapeutic Revenue in Global Market (2017-2022)
7.8.5 Bayer AG Key News
7.9 AstraZeneca
7.9.1 AstraZeneca Corporate Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Renal Therapeutic Major Product Offerings
7.9.4 AstraZeneca Renal Therapeutic Revenue in Global Market (2017-2022)
7.9.5 AstraZeneca Key News
7.10 Vifor Pharma Group
7.10.1 Vifor Pharma Group Corporate Summary
7.10.2 Vifor Pharma Group Business Overview
7.10.3 Vifor Pharma Group Renal Therapeutic Major Product Offerings
7.10.4 Vifor Pharma Group Renal Therapeutic Revenue in Global Market (2017-2022)
7.10.5 Vifor Pharma Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Renal Therapeutic Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|